Invesco Ltd. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$76,000
-93.4%
58,745
-93.6%
0.00%
Q4 2021$1,157,000
-40.8%
910,909
+1.6%
0.00%
Q3 2021$1,955,000
-41.4%
896,475
+0.7%
0.00%
-100.0%
Q2 2021$3,339,000
+24.5%
890,342
+8.2%
0.00%0.0%
Q1 2021$2,682,000
-10.1%
822,556
-5.9%
0.00%0.0%
Q4 2020$2,982,000
-14.5%
874,514
+2.3%
0.00%0.0%
Q3 2020$3,488,000
+42.3%
854,734
+17.9%
0.00%0.0%
Q2 2020$2,451,000
+43.5%
725,176
-1.1%
0.00%0.0%
Q1 2020$1,708,000
-28.8%
733,125
+11.2%
0.00%0.0%
Q4 2019$2,400,000
-56.8%
659,217
-1.6%
0.00%0.0%
Q3 2019$5,555,000
-13.0%
669,703
-9.7%
0.00%
-50.0%
Q2 2019$6,384,000
-40.3%
741,498
-25.9%
0.00%
-50.0%
Q1 2019$10,696,000
+11.7%
1,000,594
-8.6%
0.00%0.0%
Q4 2018$9,577,000
-58.1%
1,094,481
-19.5%
0.00%
-42.9%
Q3 2018$22,852,000
+44.9%
1,360,241
+80.8%
0.01%
+40.0%
Q2 2018$15,771,000
-19.8%
752,408
-38.5%
0.01%
-28.6%
Q1 2018$19,671,000
+40.6%
1,222,526
+65.5%
0.01%
+40.0%
Q4 2017$13,994,000
+152.7%
738,472
+87.7%
0.01%
+150.0%
Q3 2017$5,537,000
+216.0%
393,459
+67.4%
0.00%
+100.0%
Q2 2017$1,752,000
+22.9%
235,105
+7.2%
0.00%
Q1 2017$1,425,000
+49.8%
219,223
+2.1%
0.00%
Q4 2016$951,000
-70.9%
214,667
-69.3%
0.00%
-100.0%
Q3 2016$3,269,000
-25.4%
699,892
+4.9%
0.00%
-50.0%
Q2 2016$4,384,000
+96.4%
667,368
+90.1%
0.00%
+100.0%
Q1 2016$2,232,000
+53.3%
351,000
+45.4%
0.00%0.0%
Q4 2015$1,456,000
+7.6%
241,392
+6.7%
0.00%0.0%
Q3 2015$1,353,000
+1.9%
226,259
+16.5%
0.00%0.0%
Q2 2015$1,328,000
+27.1%
194,137
+12.7%
0.00%
Q1 2015$1,045,000
+2.1%
172,225
+16.6%
0.00%
Q4 2014$1,024,000
-18.6%
147,712
-4.4%
0.00%
-100.0%
Q3 2014$1,258,000
+3.3%
154,574
+3.2%
0.00%
Q2 2014$1,218,000
-10.9%
149,838
-14.0%
0.00%
-100.0%
Q1 2014$1,367,000
+7.5%
174,316
+21.2%
0.00%0.0%
Q4 2013$1,272,000
+13.7%
143,769
+7.7%
0.00%
Q3 2013$1,119,000
-92.3%
133,538
-93.1%
0.00%
-100.0%
Q2 2013$14,447,0001,936,6140.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders